COURSE OF SYSTEMIC LUPUS ERYTHEMATOSUS DEPENDING ON CLIMATE AND GEOGRAPHICAL CHARACTERISTICS
Keywords:
Systemic lupus erythematosus, myocarditis, endocarditis, pneumonitis, climateAbstract
Explicit clinical symptoms of heart failure in systemic lupus erythematosus are found in 51.4% of patients. Lung damage in SLE is often indicated as an infectious complication due to immunosuppressive therapy, especially long-term treatment with large doses of corticosteroids, rather than as a result of the severe course of the disease itself. Frequent symptoms of damage to the nervous system were sleep disturbances, which manifested itself in the form of lengthening the time of falling asleep, reducing the depth and duration of night sleep, rapid awakening and daytime sleepiness. Uncontrolled activity of the lupus process caused the appearance of severe manifestations, such as pneumonitis, pleurisy and pericarditis (serosites and polyserosites) and vasculitis.
References
Alekberova Z.S., Nasonova V.A., Reshetnyak T.M., Tsitlanadze V.G., Kalandadze N.
//Features of systemic lupus erythematosus in Russians and Georgians. Scientific and practical rheumatology. No. 2, 2001, p. 18-22.
Demin A.A., Sentyakova T.N. Synchronizing therapy with plasmapheresis and cyclophosphamide of rapidly progressing systemic lupus erythematosus with kidney involvement. // Ter.arch., 1996, No. 5, 27-30.
Ivanova M.M., Soloviev S.K. Achievements and new approaches to the treatment of SLE. Scientific and practical rheumatology. No. 2, 2009, p. 18-22.
Ilyina A.E. Cardiovascular pathology in systemic lupus erythematosus in men. Dissertation...
k. m. N. Moscow, 2009 159 p.
Kalandadze N.G. Early diagnosis, peculiarities of treatment and clinical examination of SLE patients., 1998
Kotovskaya M.A., Nasonov E.L. Role of anti-nucleosomal antibodies in SLE. Scientific and practical rheumatology. No. 4, 2006, p. 80-85.
Lila V.A., Mazurov V.I., Lila A.M. "Incomplete" systemic lupus erythematosus in real clinical practice: diagnostic difficulties. Journal "Therapy" No. 2. Moscow., 2022.
Ospanova S.N. Analysis of SLE clinical polymorphism in the Semipalatinsk region. SB RAMS Bulletin. №1 (107). Page 94-96.
Rasulov U.R. Features of the clinical course of diffuse connective tissue diseases in the conditions of Tajikistan. Autoreferat diss. cand. honey. sciences. M., 1999
Hassan Mohildane Abdel Marouf. Investigation of mechanisms of regulation of peripheral blood leukocyte apoptosis in patients with systemic lupus erythematosus. dissertation... Candidate of Biological Sciences, Moscow. 2009. 162 p.
Bertsias G., Salmon J., Boumpas D. Therapeutic opportunites in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 2010; 69:1603-11.
Calvo-Alen J., Bastian H., Straaton K. et al. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at the large tertiary care center. Arthr Rheum 1995; 38:1475-84."
Crowson A.N., Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutaneous Pathol 2001; 28:1-23.
Fernandez A., Quintana G., Matteson E.L. et al. Lupus arthropathy: Historical evolution from deforming arthritis to rhupus. Clin Rheumatol 2004; 23:523-6.
Garton M.J., Isenberg D.A. Clinical features of lupus myositis versus idiopathic myositis: A review of 30 cases. Br J Rheum 1997; 36:1067-74.
